Sulnox Group PLC

Share Issue/Capital Change • Jun 27, 2023

National Storage Mechanism | Additional information

RNS Number : 0998E

SulNOx Group PLC

27 June 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

27 June 2023

SulNOx Group Plc (the "Company" or "SulNOx")

Proposed Fundraising

(Aquis Stock Exchange: SNOX)

The board of directors of the Company (the "Board") is pleased to announce that it is in the process of finalising an agreement (the "Proposed Agreement") with a new strategic investor (the "Investor") pursuant to which the Investor would agree to subscribe for new ordinary shares of 2 pence each ("Ordinary Shares") at a price of 9.5 pence per share (representing a small discount to the closing price per SulNOx share of 11 pence on 26 June 2023 (the "Closing Price")). It is expected that the funds raised under the Proposed Agreement would be utilised for general working capital purposes.

Separately, the Investor has joined the Company in a consultancy role (the "Consultancy"), as part of which, it is anticipated that the Company will grant options to subscribe for new Ordinary Shares at a price of 10 pence per share (again, representing a small discount to the Closing Price).

The anticipated Ordinary Shares to be allotted under the Proposed Agreement and options granted under the Consultancy will utilise SulNOx's existing unspent share issue authorities. 

The Board hopes to finalise the Proposed Agreement within the next week and a further announcement will be made in due course.

- Ends -

For further information please contact:

SulNOx Group plc Steven Cowin, CFO	Tel: 07624 491 821
Allenby Capital Limited (AQSE Corporate Adviser) Nick Harriss / John Depasquale	Tel: 020 3328 5656

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXUBVVROSUNUAR